GC
XENT

Globeflex Capital’s Intersect ENT, Inc XENT Stock Holding History

Globeflex Capital’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-69,517
Closed -$841K – 577
2016
Q4 		$841K Buy
+69,517
New +$900K 0.21% 187
2015
Q4 		– Sell
-38,700
Closed -$906K – 525
2015
Q3 		$906K Buy
+38,700
New +$1.07M 0.19% 178

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Globeflex Capital's XENT Position: Q1 2017 in Review

Globeflex Capital sold out of Intersect ENT, Inc (XENT) in Q1 2017, closing a stake of 69,517 shares — an estimated $841K sold.

Globeflex Capital first reported a position in XENT in Q3 2015 and held it in 2 quarters. The position peaked at $906K in Q3 2015. 106 funds tracked by Wall St. Rank hold XENT as of Q1 2017.

  • Globeflex Capital reported no remaining Intersect ENT, Inc position as of Q1 2017 after selling out during the quarter.
  • Globeflex Capital sold 69,517 Intersect ENT, Inc shares in Q1 2017, an estimated $841K.
  • Globeflex Capital first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 2 quarters.
  • Globeflex Capital's Intersect ENT, Inc position peaked at $906K in Q3 2015.
  • 106 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2017.

Based on Globeflex Capital's 13F filing for Q1 2017, filed 12 May 2017.